He Q, Zhang R, Tury S, Courgnaud V, Liu F, Battini J
Nat Commun. 2025; 16(1):683.
PMID: 39814721
PMC: 11736019.
DOI: 10.1038/s41467-025-55995-8.
Bhardwaj R, Kumar L, Chhabra D, Sharma A, Mohanty S, Mehra N
Int J Hematol Oncol Stem Cell Res. 2024; 18(4):330-343.
PMID: 39703476
PMC: 11652691.
DOI: 10.18502/ijhoscr.v18i4.16758.
Gelbard M, Grace M, von Schoeler-Ames A, Gnanou I, Munger K
Tumour Virus Res. 2024; 19():200300.
PMID: 39643241
PMC: 11714379.
DOI: 10.1016/j.tvr.2024.200300.
Kim J, Sohn H, Shin H, Walz S, Jung S
Parasites Hosts Dis. 2024; 62(4):385-398.
PMID: 39622651
PMC: 11614482.
DOI: 10.3347/PHD.24025.
Jiang Z, Meyer A, Yang W, Donoghue D
Heliyon. 2024; 10(16):e36278.
PMID: 39253179
PMC: 11381775.
DOI: 10.1016/j.heliyon.2024.e36278.
Critical domains for NACC2-NTRK2 fusion protein activation.
Yang W, Meyer A, Jiang Z, Jiang X, Donoghue D
PLoS One. 2024; 19(6):e0301730.
PMID: 38935636
PMC: 11210774.
DOI: 10.1371/journal.pone.0301730.
External Guide Sequence Effectively Suppresses the Gene Expression and Replication of Herpes Simplex Virus 2.
Yan B, Liu Y, Chen Y, Liu F
Molecules. 2024; 29(9).
PMID: 38731543
PMC: 11085068.
DOI: 10.3390/molecules29092052.
V3: an enigmatic isoform of the proteoglycan versican.
Wight T, Day A, Kang I, Harten I, Kaber G, Briggs D
Am J Physiol Cell Physiol. 2023; 325(2):C519-C537.
PMID: 37399500
PMC: 10511178.
DOI: 10.1152/ajpcell.00059.2023.
Suppressing Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Expression and Replication by RNase P Ribozyme.
Liu Y, Chen Y, Yan B, Liu F
Molecules. 2023; 28(8).
PMID: 37110852
PMC: 10142857.
DOI: 10.3390/molecules28083619.
Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.
Wang C, Peiris M, Meyer A, Nelson K, Donoghue D
Oncotarget. 2023; 14:133-145.
PMID: 36780330
PMC: 9924825.
DOI: 10.18632/oncotarget.28359.
Identification of Copper Transporter 1 as a Receptor for Feline Endogenous Retrovirus ERV-DC14.
Tury S, Giovannini D, Ivanova S, Touhami J, Courgnaud V, Battini J
J Virol. 2022; 96(12):e0022922.
PMID: 35652657
PMC: 9215233.
DOI: 10.1128/jvi.00229-22.
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.
McCubrey J, Meher A, Akula S, Abrams S, Steelman L, Lahair M
Aging (Albany NY). 2022; 14(8):3365-3386.
PMID: 35477123
PMC: 9085237.
DOI: 10.18632/aging.204038.
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.
Abrams S, Duda P, Akula S, Steelman L, Follo M, Cocco L
Cells. 2022; 11(5).
PMID: 35269416
PMC: 8909756.
DOI: 10.3390/cells11050794.
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
McCubrey J, Abrams S, Steelman L, Cocco L, Ratti S, Martelli A
Biomolecules. 2022; 12(2).
PMID: 35204775
PMC: 8961609.
DOI: 10.3390/biom12020276.
Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen.
Roth M, McDaniel Y, Daly M, Talledge N, Greggs 3rd W, Patterson S
J Mol Biol. 2021; 433(18):167111.
PMID: 34153286
PMC: 8380735.
DOI: 10.1016/j.jmb.2021.167111.
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Abrams S, Akula S, Meher A, Steelman L, Gizak A, Duda P
Cells. 2021; 10(4).
PMID: 33917370
PMC: 8067414.
DOI: 10.3390/cells10040816.
Characterization and Functional Analysis of CD44v6.CAR T Cells Endowed with a New Low-Affinity Nerve Growth Factor Receptor-Based Spacer.
Stornaiuolo A, Valentinis B, Sirini C, Scavullo C, Asperti C, Zhou D
Hum Gene Ther. 2021; 32(13-14):744-760.
PMID: 33554732
PMC: 8312023.
DOI: 10.1089/hum.2020.216.
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
Tandon R, Mitra D, Sharma P, McCandless M, Stray S, Bates J
Sci Rep. 2020; 10(1):19076.
PMID: 33154514
PMC: 7645753.
DOI: 10.1038/s41598-020-76135-w.
Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors.
Li F, Meyer A, Peiris M, Nelson K, Donoghue D
Transl Oncol. 2020; 13(12):100853.
PMID: 32854034
PMC: 7451725.
DOI: 10.1016/j.tranon.2020.100853.
Differential Effects of Human Adenovirus E1A Protein Isoforms on Aerobic Glycolysis in A549 Human Lung Epithelial Cells.
Prusinkiewicz M, Tu J, Dodge M, MacNeil K, Radko-Juettner S, Fonseca G
Viruses. 2020; 12(6).
PMID: 32503156
PMC: 7354625.
DOI: 10.3390/v12060610.